Seroatlas · Human Serome Atlas

ATP5MC3

ATP synthase F(0) complex subunit C3, mitochondrial

Also known as: AT5G3_HUMAN, ATP5G3

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P48201
Gene
ATP5MC3
Ensembl
ENSG00000154518
Chromosome
2
Canonical length
142 aa
Protein class
Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters

OverviewNCBI Gene

This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene is one of three genes that encode subunit c of the proton channel. Each of the three genes have distinct mitochondrial import sequences but encode the identical mature protein. Alternatively spliced transcript variants encoding different proteins have been identified. [provided by RefSeq, Jun 2010]

Canonical amino-acid sequenceUniProt

142 residues, UniProt reviewed canonical sequence.

>P48201|ATP5MC3
     1  MFACAKLACT PSLIRAGSRV AYRPISASVL SRPEASRTGE GSTVFNGAQN GVSQLIQREF
    61  QTSAISRDID TAAKFIGAGA ATVGVAGSGA GIGTVFGSLI IGYARNPSLK QQLFSYAILG
   121  FALSEAMGLF CLMVAFLILF AM

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ATP5MC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
2
Mean surface accessibility (rSASA)
0.52
Highest tissue expression
1,149 nTPM

Expression across tissuesHPA

Tissue

  • heart muscle: 1,149 nTPM
  • tongue: 1,015 nTPM
  • skeletal muscle: 728 nTPM
  • parathyroid gland: 515 nTPM
  • kidney: 416 nTPM
  • liver: 371 nTPM

Single-cell type

  • parietal cells: 3,391 nCPM
  • esophageal basal cells: 1,737 nCPM
  • esophageal suprabasal cells: 1,722 nCPM
  • enteric transient amplifying cells: 1,479 nCPM
  • colonocytes: 1,455 nCPM
  • enterocytes: 1,330 nCPM

Immune cell

  • total PBMC: 439 nTPM
  • myeloid DC: 426 nTPM
  • intermediate monocyte: 333 nTPM
  • plasmacytoid DC: 315 nTPM
  • non-classical monocyte: 311 nTPM
  • classical monocyte: 295 nTPM

Brain region

  • choroid plexus: 141 nTPM
  • hypothalamus: 133 nTPM
  • cerebellum: 123 nTPM
  • pons: 116 nTPM
  • medulla oblongata: 109 nTPM
  • thalamus: 109 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ATP5MC3.

Disease | AllUniProt

Conditions ATP5MC3 is implicated in, by any mechanism.

Disease | GeneticClinVar

3 pathogenic / likely-pathogenic of 37 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.83
gnomAD pLI
0.26
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ATP5MC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ATP5MC3 as an antibody target. Whether an autoantibody or antibody against ATP5MC3 could matter depends on whether native ATP5MC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ATP5MC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ATP5MC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ATP5MC3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...